LimFlow SA: LimFlow Raises $40 Million (€36 Million) in Series D Financing
Funds to Support Completion of Clinical Program Through Commercialization of Novel Device Designed to Prevent Amputations in Patients with Chronic Limb-Threatening Ischemia LimFlow SA, a pioneer
Source: finanznachrichten.de